9-72789120-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138691.3(TMC1):c.1030-3C>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000869 in 1,611,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138691.3 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMC1 | NM_138691.3 | c.1030-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000297784.10 | |||
TMC1 | XM_017014256.2 | c.1033-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMC1 | ENST00000297784.10 | c.1030-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_138691.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152042Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250358Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135434
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1459918Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 726258
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152042Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74270
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 28, 2017 | The c.1030-3C>T variant in TMC1 has not been previously reported in individuals with hearing loss, but has been identified in 1/4406 African American chromosome s by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSN P rs370872111). Although this variant has been seen in the general population, i ts frequency is not high enough to rule out a pathogenic role. This variant is l ocated in the 3' splice region. Computational tools do not suggest an impact to splicing. However, this information is not predictive enough to rule out pathoge nicity. In summary, the clinical significance of the c.1030-3C>T variant is unce rtain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at